Medipal Holdings (TSE:7459) Other Current Receivables: 円69,794 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7459 Medipal Holdings Corp TSE:7459
82 GF Score
Price 円2,854.00
GF Value 円2,734.77
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Medipal Holdings Other Current Receivables?

Medipal Holdings TSE:7459 -0.64% 82 Other Current Receivables is 円69,794 Mil as of Mar. 2026. GuruFocus rates TSE:7459 with a GF Score™ of 82/100 and a GF Value™ of 円2,734.77 (Fairly Valued). The stock has 5 warning signs investors should review.

Medipal Holdings's Other Current Receivables for the quarter that ended in Mar. 2026 was 円69,794 Mil.

Medipal Holdings's quarterly Other Current Receivables stayed the same from Sep. 2025 (円0.00 Mil) to Dec. 2025 (円0.00 Mil) but then increased from Dec. 2025 (円0.00 Mil) to Mar. 2026 (円69,794.00 Mil).

Medipal Holdings's annual Other Current Receivables increased from Mar. 2024 (円66,516.00 Mil) to Mar. 2025 (円66,826.00 Mil) and increased from Mar. 2025 (円66,826.00 Mil) to Mar. 2026 (円69,794.00 Mil).

Medipal Holdings Other Current Receivables Related Terms

Medipal Holdings Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Medipal Holdings's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medipal Holdings Other Current Receivables Chart

Medipal Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 63,691.00 67,865.00 66,516.00 66,826.00 69,794.00

Medipal Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66,826.00 0.00 0.00 0.00 69,794.00
TSE:7459
82GF Score
Medipal Holdings Corp TSE:7459
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medipal Holdings Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of 円69,794 Mil mean?
Medipal Holdings (TSE:7459) has a Other Current Receivables of 円69,794 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Medipal Holdings and its competitors.
Is Medipal Holdings' Other Current Receivables too high?
Medipal Holdings' current Other Current Receivables is 円69,794 Mil. Overall, Medipal Holdings has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Other Current Receivables compare to MCK and CAH?
Medipal Holdings' Other Current Receivables of 円69,794 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Distribution company?
A good Other Current Receivables depends on the Medical Distribution industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Medipal Holdings and its competitors. Medipal Holdings's current Other Current Receivables is 円69,794 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (TSE:7459) is currently considered Fairly Valued. The stock's GF Value™ is 円2,734.77, compared to a current price of 円2,854.00 — trading 4.4% above its estimated fair value. The current Other Current Receivables is 円69,794 Mil. Medipal Holdings' overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Medipal Holdings (TSE:7459), the current Other Current Receivables is 円69,794 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medipal Holdings (TSE:7459) Overvalued in 2026?

Based on GuruFocus' analysis, Medipal Holdings stock appears to be overvalued. The current stock price of 円2,854.00 is trading 4.4% above its estimated GF Value™ of 円2,734.77. GuruFocus considers Medipal Holdings to be Fairly Valued.

Key valuation signals for TSE:7459:

  • Other Current Receivables: 円69,794 Mil
  • GF Value™: 円2,734.77 vs. price of 円2,854.00 (4.4% above fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the TSE:7459 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medipal Holdings Business Description

Other Exchanges MEPDF:USAMAHLY:USA
Address 3-1-1 Kyobashi, Chuo-ku, Tokyo, JPN, 104-8461
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
82GF Score

Get the complete analysis for TSE:7459

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,854.00
Price
円2,734.77
GF Value